Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study

Omalizumab was as effective in reducing ED visits, controlling asthma symptoms, and reducing the need for systemic corticosteroids in patients with IgE levels greater than 700 IU/mL compared with patients with levels of 30 to 700 IU/mL.